{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:07:48Z","timestamp":1788829668770,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.crad.2026.107390","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T23:27:49Z","timestamp":1779492469000},"page":"107390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Delayed 18F-FDG PET for the evaluation of suspected recurrent disease in brain metastases treated with radiation"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-0724","authenticated-orcid":false,"given":"B.","family":"Ciavarra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3686-9388","authenticated-orcid":false,"given":"A.","family":"Krayyem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1319-6319","authenticated-orcid":false,"given":"S.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Shindell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Gule-Monroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0787-0634","authenticated-orcid":false,"given":"C.B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7724-5784","authenticated-orcid":false,"given":"J.M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2026.107390_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/neuonc\/nov301","article-title":"A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation","volume":"18","author":"Hatzoglou","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.crad.2026.107390_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3174\/ajnr.A5472","article-title":"Diagnostic accuracy of amino acid and FDG-PET in differentiating brain metastasis recurrence from radionecrosis after radiotherapy: a systematic review and meta-analysis","volume":"39","author":"Li","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.crad.2026.107390_bib3","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3174\/ajnr.A4475","article-title":"Diagnostic accuracy of PET, SPECT, and arterial spin-labeling in differentiating tumor recurrence from necrosis in cerebral metastasis after stereotactic radiosurgery","volume":"36","author":"Lai","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.crad.2026.107390_bib4","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00415-009-5034-5","article-title":"Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence","volume":"256","author":"Hoefnagels","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.crad.2026.107390_bib5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.mri.2011.04.004","article-title":"Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling","volume":"29","author":"Huang","year":"2011","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.crad.2026.107390_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-009-0106-z","article-title":"Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery","volume":"99","author":"Mitsuya","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.crad.2026.107390_bib7","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.2214\/AJR.18.19674","article-title":"Comparison of MRI and PET as potential surrogate endpoints for treatment response after stereotactic radiosurgery in patients with brain metastasis","volume":"211","author":"Suh","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2026.107390_bib8","first-page":"859","article-title":"Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not","volume":"27","author":"Boxerman","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.crad.2026.107390_bib9","doi-asserted-by":"crossref","first-page":"W495","DOI":"10.2214\/AJR.12.9544","article-title":"Perfusion MRI: the five most frequently asked clinical questions","volume":"201","author":"Essig","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2026.107390_bib10","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.3174\/ajnr.A4341","article-title":"ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain","volume":"36","author":"Welker","year":"2015","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.crad.2026.107390_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2214\/AJR.19.22571","article-title":"The role of dual-phase FDG PET\/CT in the diagnosis and follow-up of brain tumors","volume":"215","author":"\u00d6z\u00fctemiz","year":"2020","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.crad.2026.107390_bib12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2967\/jnumed.110.085324","article-title":"Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation","volume":"52","author":"Prieto","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2026.107390_bib13","first-page":"281","article-title":"Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy","volume":"19","author":"Ceccon","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.crad.2026.107390_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/neuonc\/now310","article-title":"O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis","volume":"19","author":"Heinzel","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.crad.2026.107390_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.113.121418","article-title":"(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment","volume":"55","author":"Lizarraga","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2026.107390_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132515","article-title":"Differentiation of brain tumor recurrence from post-radiotherapy necrosis with 11C-methionine PET: visual assessment versus quantitative assessment","volume":"10","author":"Minamimoto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.crad.2026.107390_bib17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1148\/radiology.144.4.6981123","article-title":"Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain","volume":"144","author":"Patronas","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2026.107390_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13014-016-0713-8","article-title":"Suspected recurrence of brain metastases after focused high dose radiotherapy: can [(18)F]FET-PET overcome diagnostic uncertainties?","volume":"11","author":"Romagna","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.crad.2026.107390_bib19","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3174\/ajnr.A5252","article-title":"Differentiation between treatment-induced necrosis and recurrent tumors in patients with metastatic brain tumors: comparison among (11)C-methionine-PET, FDG-PET, MR permeability imaging, and MRI-ADC\u2014preliminary results","volume":"38","author":"Tomura","year":"2017","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.crad.2026.107390_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ijc.1016","article-title":"The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery","volume":"96","author":"Chao","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.crad.2026.107390_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/neuonc\/noz003","article-title":"PET imaging in patients with brain metastasis\u2014report of the RANO\/PET group","volume":"21","author":"Galldiks","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.crad.2026.107390_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2967\/jnumed.122.264859","article-title":"Amino acid PET in neurooncology","volume":"64","author":"Galldiks","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2026.107390_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13550-020-00739-6","article-title":"[(18)F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis","volume":"10","author":"Parent","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.crad.2026.107390_bib24","series-title":"Decision memo for positron emission tomography (FDG) for solid tumors (CAG-00181R4)","year":"2013"},{"key":"10.1016\/j.crad.2026.107390_bib25","series-title":"Fluorodopa F 18 injection: highlights of prescribing information (NDA 212123)","year":"2019"},{"key":"10.1016\/j.crad.2026.107390_bib26","series-title":"Fast facts on U.S. hospitals","year":"2023"},{"key":"10.1016\/j.crad.2026.107390_bib27","series-title":"U.S. nuclear medicine and PET imaging equipment market to reach $700 million by 2026","year":"2020"},{"key":"10.1016\/j.crad.2026.107390_bib28","series-title":"National coverage determination (NCD) for positron emission tomography (FDG). NCD 220.6.17","year":"2023"},{"key":"10.1016\/j.crad.2026.107390_bib29","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2214\/AJR.06.1175","article-title":"The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence development","volume":"188","author":"Lindsay","year":"2007","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.crad.2026.107390_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5272\/jimab.2013191.367","article-title":"Delayed FDG-PET\/CT images in patients with brain tumors\u2014impact on visual and semiquantitative assessment","volume":"19","author":"Bochev","year":"2013","journal-title":"J IMAB"},{"key":"10.1016\/j.crad.2026.107390_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11060-010-0365-8","article-title":"Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis","volume":"103","author":"Horky","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.crad.2026.107390_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1148\/rg.232025103","article-title":"Radionuclide bone imaging: an illustrative review","volume":"23","author":"Love","year":"2003","journal-title":"Radiographics"},{"key":"10.1016\/j.crad.2026.107390_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.crad.2026.107390_bib34","first-page":"1653","article-title":"18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter","volume":"45","author":"Spence","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2026.107390_bib35","article-title":"Number needed to scan: evidence-based point-of-care ultrasound (POCUS)","volume":"13","author":"Amini","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.crad.2026.107390_bib36","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.3174\/ajnr.A5276","article-title":"The concept of \u201cnumber needed to image\u201d","volume":"38","author":"Haller","year":"2017","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.crad.2026.107390_bib37","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/RLU.0000000000004305","article-title":"Delayed [18F]-FDG PET imaging increases diagnostic performance and reproducibility to differentiate recurrence of brain metastases from radionecrosis","volume":"47","author":"Otman","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2026.107390_bib38","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/RLU.0b013e3181db4cfb","article-title":"The efficacy of dual time point F-18 FDG PET imaging for grading of brain tumors","volume":"35","author":"Kim","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2026.107390_bib39","first-page":"407","article-title":"Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?","volume":"19","author":"Ricci","year":"1998","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.crad.2026.107390_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02841850500335101","article-title":"FDG-PET on irradiated brain tumor: ten years\u2019 summary","volume":"47","author":"Wang","year":"2006","journal-title":"Acta Radiol"},{"key":"10.1016\/j.crad.2026.107390_bib41","unstructured":"BLINDED FOR REVIEW."},{"key":"10.1016\/j.crad.2026.107390_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13311-016-0507-6","article-title":"Modified criteria for radiographic response assessment in glioblastoma clinical trials","volume":"14","author":"Ellingson","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.crad.2026.107390_bib43","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1200\/JCO.2017.72.7511","article-title":"Response assessment in neuro-oncology clinical trials","volume":"35","author":"Wen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.crad.2026.107390_bib44","doi-asserted-by":"crossref","first-page":"iv55","DOI":"10.1093\/neuonc\/nos199","article-title":"Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments","volume":"14","author":"Ruda","year":"2012","journal-title":"Neuro Oncol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026001662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026001662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:26:23Z","timestamp":1788827183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926026001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":44,"alternative-id":["S0009926026001662"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2026.107390","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed 18F-FDG PET for the evaluation of suspected recurrent disease in brain metastases treated with radiation","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2026.107390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107390"}}